TITLE

Contra Pfizer

AUTHOR(S)
Healy, David
PUB. DATE
November 2005
SOURCE
Ethical Human Psychology & Psychiatry;Fall/Winter2005, Vol. 7 Issue 3, p181
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Against a background of longstanding concerns that antidepressants may trigger suicidality, the Food and Drug Administration (FDA) in 2004 convened two committees to review the issues. Prior to the second meeting Pfizer posted an extensive ad hominem attack on me on FDA's website. There was no opportunity to post a response. This article covers the points made in response and sheds some light on pharmaceutical company handling of debates about adverse events.
ACCESSION #
25237119

 

Related Articles

  • Public health advisory on antidepressant use in adults.  // Patient Care;Aug2005, Vol. 39 Issue 8, p8 

    Reports on a public health advisory issued by the U.S. Food and Drug Administration on the possible links between antidepressant use in adults and suicidal behavior. Increase in the risk of adult suicidal behavior when being treated with antidepressants according to scientific reports.

  • TEENS AND DEPRESSION.  // Time International (South Pacific Edition);8/30/2004, Issue 34, p75 

    The article reports on an announcement by the U.S. Food and Drug Administration (FDA) that a new analysis of clinical data supports the idea that some antidepressant drugs increase the risk of suicide in teens. A decision by the PDA on new warning labels will probably come in September 2004....

  • FDA Warnings and Suicide Rates: Unintended Consequences. Sussman, Norman // Primary Psychiatry;Oct2008, Vol. 15 Issue 10, p22 

    The author reflects on the warning issued by the U.S. Food and Drug Administration (FDA) regarding the increased risk of suicide for youths taking antidepressants. Data from the National Vital Statistics Systems revealed that rate of suicide among youths decreased by 5.3% between 2004 and 2005....

  • Drugs for Depression May Trigger Suicidal Thoughts, Acts in Children at Risk for Bipolar Disorder, Says Parent Group.  // Ascribe Newswire: Medicine;2/6/2004, p9 

    The Child & Adolescent Bipolar Foundation (CABF) on February 6, 2004, on behalf of its 17,000 member families, called for the U.S. Food and Drug Administration (FDA) to add black box warnings to certain medications used to treat depression in children. CABF Board Member and parent Rachel Adler...

  • Antidepressants: Bitter pills. Check, Erika // Nature;9/9/2004, Vol. 431 Issue 7005, p122 

    Reports on the investigation on the adverse effects of antidepressants on children in the U.S. Meeting of the U.S. Food and Drug Administration to consider the scientific evidence on giving drugs called selective serotonin reuptake inhibitors; Accounts on the testimony of parents who committed...

  • Benefits outweigh risks in treatment of depressed youth. Sipkoff, Martin // Drug Topics;3/6/2006, Vol. 150 Issue 5, p3s 

    The article reports that the U.S. Food and Drug Administration (FDA) ordered black box warnings for antidepressants stating that the drugs may increase the risk of pediatric suicidal thinking and behavior. According to a review of psychological autopsy studies by the American College of...

  • US FDA warns Pfizer over tardy pharmacovigilance.  // Reactions Weekly;6/19/2010, Issue 1306, p2 

    The article reports on the 12-page letter issued by the U.S. Food and Drug Administration (FDA) to Pfizer company in June 2010 which addresses the company's failure to report potential drug side effects in a timely fashion.

  • FDA Panel Seeks to Balance Risks in Warnings for Antidepressants. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;2/14/2007, Vol. 297 Issue 6, p573 

    This article presents a look at a vote by the United States Food and Drug Administration advisory committee that determined that antidepressants should extend black box warnings, such as those that have an increased risk of suicidal thoughts and behaviors in children, adolescents, and young...

  • Youth Depression and Suicide. Docksai, Rick // Futurist;Jan/Feb2009, Vol. 43 Issue 1, p16 

    The article reports on the impact of medical advisory warnings on antidepressants on the youth suicide rate in the U.S. According to a study on antidepressants and youth suicide rates, warning labels meant to protect young people might be doing them more harm than good. It is said that the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics